Drug Markets/Pegfilgrastim

Pegfilgrastim

2 NDCs across 2 manufacturers|0 Generic,2 Brand

Pegfilgrastim is used to treat neutropenia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $96 million on Pegfilgrastim across 14,000 claims for 4,336 beneficiaries.

Pegfilgrastim is available as 2 NDCs from 2 manufacturers (0 generic, 2 brand), with NADAC prices from $3185.94 to $10074.86 per ML — the most expensive product costs about 3.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

2

competing in market

Price Spread

$3185.94 – $10074.86

per ML

7d Activity

2 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

2 manufacturers producing PEGFILGRASTIM

Drug Portfolio

2 NDCs total, 2 shown

Drug ↕Price 7d Change ↕
NEULASTA 6 MG/0.6 ML SYRINGE
$10074.8571
per ML
—
FULPHILA 6 MG/0.6 ML SYRINGE
$3185.9367
per ML
—

Frequently Asked Questions

What is Pegfilgrastim used to treat?

Pegfilgrastim is used to treat neutropenia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Pegfilgrastim?

In 2024, Medicare Part D spent $96 million on Pegfilgrastim across 14,000 claims for 4,336 beneficiaries.

How many Pegfilgrastim products are on the market?

The Pegfilgrastim drug market contains 2 NDCs from 2 manufacturers — 0 generic and 2 brand products.

What is the price range for Pegfilgrastim?

NADAC reference prices for Pegfilgrastim range from $3185.9367 to $10074.8571 per ML — the most expensive product costs about 3.2× the cheapest.

Which manufacturers make Pegfilgrastim?

2 manufacturers list Pegfilgrastim in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (1), Mylan Institutional LLC (1).